This phenomenon, termed hereditary cancer, results from germline mutations in certain predisposition genes, such as the breast cancer susceptibility gene (BRCA1/2) in breast cancer and the MutS homolog 2 (MSH2) gene in colon cancer [36]. This evidence concerns the gene MSH2 and breast carcinoma.